CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Treasury Stock	Additional paid-in capital	Retained earnings (Accumulated deficit)	Accumulated other comprehensive income (loss)	Noncontrolling interest in subsidiary
Common Stock, beginning balance (in shares) at Dec. 31, 2021		133,844,000
Preferred Stock, beginning balance (in shares) at Dec. 31, 2021			124,000
Treasury Stock, beginning balance (in shares) at Dec. 31, 2021				0
Balance at beginning of period at Dec. 31, 2021	$ 2,066,689	$ 13	$ 1	$ 0	$ 2,107,267	$ (43,021)	$ (2,354)	$ 4,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		187,000
Equity-based compensation	5,502				5,502
Exercise of stock options (in shares)		184,000
Exercise of stock options	723				723
Payments for tax withholdings from restricted stock vesting and stock option exercises	(1,269)				(1,269)
Common Stock issued in connection with employee stock purchase plan (in shares)		31,000
Common Stock issued in connection with employee stock purchase plan	753				753
Net income	42,230					41,750		480
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	5,998						5,998
Common Stock, ending balance (in shares) at Mar. 31, 2022		134,246,000
Preferred Stock, ending balance (in shares) at Mar. 31, 2022			124,000
Treasury Stock, ending balance (in shares) at Mar. 31, 2022				0
Balance at end of period at Mar. 31, 2022	2,120,626	$ 13	$ 1	$ 0	2,112,976	(1,271)	3,644	5,263
Common Stock, beginning balance (in shares) at Dec. 31, 2021		133,844,000
Preferred Stock, beginning balance (in shares) at Dec. 31, 2021			124,000
Treasury Stock, beginning balance (in shares) at Dec. 31, 2021				0
Balance at beginning of period at Dec. 31, 2021	2,066,689	$ 13	$ 1	$ 0	2,107,267	(43,021)	(2,354)	4,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 1,400
Shares purchased under share repurchase program (in shares)	750,835
Shares purchased under share repurchase program	$ (14,000)
Reclassification of warrant liability to equity for exercised warrants (in shares)	87,553
Reclassification of warrant liability to equity for exercised warrants	$ 2,103
Net income	74,704
Common Stock, ending balance (in shares) at Sep. 30, 2022		134,723,000
Preferred Stock, ending balance (in shares) at Sep. 30, 2022			124,000
Treasury Stock, ending balance (in shares) at Sep. 30, 2022				751,000
Balance at end of period at Sep. 30, 2022	2,159,950	$ 13	$ 1	$ (13,992)	2,126,468	28,883	12,994	5,583
Common Stock, beginning balance (in shares) at Mar. 31, 2022		134,246,000
Preferred Stock, beginning balance (in shares) at Mar. 31, 2022			124,000
Treasury Stock, beginning balance (in shares) at Mar. 31, 2022				0
Balance at beginning of period at Mar. 31, 2022	2,120,626	$ 13	$ 1	$ 0	2,112,976	(1,271)	3,644	5,263
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		117,000
Equity-based compensation	5,720				5,720
Exercise of stock options (in shares)		43,000
Payments for tax withholdings from restricted stock vesting and stock option exercises	(613)				(613)
Shares purchased under share repurchase program (in shares)				199,000
Shares purchased under share repurchase program	(3,375)			$ (3,375)
Reclassification of warrant liability to equity for exercised warrants (in shares)		19,000
Reclassification of warrant liability to equity for exercised warrants	495				495
Distribution to non-controlling interest	(2,000)							(2,000)
Net income	15,247					14,032		1,215
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	1,593						1,593
Common Stock, ending balance (in shares) at Jun. 30, 2022		134,425,000
Preferred Stock, ending balance (in shares) at Jun. 30, 2022			124,000
Treasury Stock, ending balance (in shares) at Jun. 30, 2022				199,000
Balance at end of period at Jun. 30, 2022	2,137,693	$ 13	$ 1	$ (3,375)	2,118,578	12,761	5,237	4,478
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		83,000
Equity-based compensation	5,562				5,562
Exercise of stock options (in shares)		99,000
Exercise of stock options	665				665
Payments for tax withholdings from restricted stock vesting and stock option exercises	(808)				(808)
Common Stock issued in connection with employee stock purchase plan (in shares)		47,000
Common Stock issued in connection with employee stock purchase plan	863				863
Shares purchased under share repurchase program (in shares)				552,000
Shares purchased under share repurchase program	(10,617)			$ (10,617)
Reclassification of warrant liability to equity for exercised warrants (in shares)		69,000
Reclassification of warrant liability to equity for exercised warrants	1,608				1,608
Net income	17,227					16,122		1,105
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	7,757						7,757
Common Stock, ending balance (in shares) at Sep. 30, 2022		134,723,000
Preferred Stock, ending balance (in shares) at Sep. 30, 2022			124,000
Treasury Stock, ending balance (in shares) at Sep. 30, 2022				751,000
Balance at end of period at Sep. 30, 2022	$ 2,159,950	$ 13	$ 1	$ (13,992)	2,126,468	28,883	12,994	5,583
Common Stock, beginning balance (in shares) at Dec. 31, 2022	134,435,119	134,435,000
Preferred Stock, beginning balance (in shares) at Dec. 31, 2022	124,060		124,000
Treasury Stock, beginning balance (in shares) at Dec. 31, 2022	750,835			751,000
Balance at beginning of period at Dec. 31, 2022	$ 2,157,758	$ 13	$ 1	$ (13,992)	2,130,148	26,295	8,693	6,600
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		292,000
Equity-based compensation	5,916				5,916
Payments for tax withholdings from restricted stock vesting and stock option exercises	(1,883)				(1,883)
Common Stock issued in connection with employee stock purchase plan (in shares)		53,000
Common Stock issued in connection with employee stock purchase plan	1,021				1,021
Shares purchased under share repurchase program (in shares)		632,000		632,000
Shares purchased under share repurchase program	(9,224)			$ (9,224)
Net income	16,675					15,707		968
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	(2,805)						(2,805)
Common Stock, ending balance (in shares) at Mar. 31, 2023		134,148,000
Preferred Stock, ending balance (in shares) at Mar. 31, 2023			124,000
Treasury Stock, ending balance (in shares) at Mar. 31, 2023				1,383,000
Balance at end of period at Mar. 31, 2023	$ 2,167,458	$ 13	$ 1	$ (23,216)	2,135,202	42,002	5,888	7,568
Common Stock, beginning balance (in shares) at Dec. 31, 2022	134,435,119	134,435,000
Preferred Stock, beginning balance (in shares) at Dec. 31, 2022	124,060		124,000
Treasury Stock, beginning balance (in shares) at Dec. 31, 2022	750,835			751,000
Balance at beginning of period at Dec. 31, 2022	$ 2,157,758	$ 13	$ 1	$ (13,992)	2,130,148	26,295	8,693	6,600
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	1,542,000
Exercise of stock options	$ 500
Shares purchased under share repurchase program (in shares)	631,953
Shares purchased under share repurchase program	$ (9,200)
Net income	$ (421,205)
Common Stock, ending balance (in shares) at Sep. 30, 2023	134,991,451	134,991,000
Preferred Stock, ending balance (in shares) at Sep. 30, 2023	124,060		124,000
Treasury Stock, ending balance (in shares) at Sep. 30, 2023	1,382,788			1,383,000
Balance at end of period at Sep. 30, 2023	$ 1,739,772	$ 13	$ 1	$ (23,216)	2,145,376	(398,097)	8,408	7,287
Common Stock, beginning balance (in shares) at Mar. 31, 2023		134,148,000
Preferred Stock, beginning balance (in shares) at Mar. 31, 2023			124,000
Treasury Stock, beginning balance (in shares) at Mar. 31, 2023				1,383,000
Balance at beginning of period at Mar. 31, 2023	2,167,458	$ 13	$ 1	$ (23,216)	2,135,202	42,002	5,888	7,568
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		156,000
Equity-based compensation	6,847				6,847
Exercise of stock options (in shares)		214,000
Payments for tax withholdings from restricted stock vesting and stock option exercises	(2,229)				(2,229)
Distribution to non-controlling interest	(2,500)							(2,500)
Net income	15,041					13,977		1,064
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	2,454						2,454
Common Stock, ending balance (in shares) at Jun. 30, 2023		134,518,000
Preferred Stock, ending balance (in shares) at Jun. 30, 2023			124,000
Treasury Stock, ending balance (in shares) at Jun. 30, 2023				1,383,000
Balance at end of period at Jun. 30, 2023	2,187,071	$ 13	$ 1	$ (23,216)	2,139,820	55,979	8,342	6,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)		176,000
Equity-based compensation	4,521				4,521
Exercise of stock options (in shares)		215,000
Exercise of stock options	538				538
Payments for tax withholdings from restricted stock vesting and stock option exercises	(513)				(513)
Common Stock issued in connection with employee stock purchase plan (in shares)		82,000
Common Stock issued in connection with employee stock purchase plan	1,010				1,010
Net income	(452,921)					(454,076)		1,155
Change in fair value of interest rate swaps, inclusive of reclassification adjustment	$ 66						66
Common Stock, ending balance (in shares) at Sep. 30, 2023	134,991,451	134,991,000
Preferred Stock, ending balance (in shares) at Sep. 30, 2023	124,060		124,000
Treasury Stock, ending balance (in shares) at Sep. 30, 2023	1,382,788			1,383,000
Balance at end of period at Sep. 30, 2023	$ 1,739,772	$ 13	$ 1	$ (23,216)	$ 2,145,376	$ (398,097)	$ 8,408	$ 7,287